To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.


Already Have an Account?

Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:19 Issue:1 Number:8 ISSN#:2564-2537
Author Verified
ACE Report #13402
Ace Report Cover Sports Medicine

No Clinical Benefit with 4 Weeks of Topical Diclofenac vs Placebo for Achilles Tendinopathy

How to Cite

OrthoEvidence. No Clinical Benefit with 4 Weeks of Topical Diclofenac vs Placebo for Achilles Tendinopathy. ACE Report. 2021;19(1):8. Available from:

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Topical diclofenac vs placebo for the treatment of chronic Achilles tendinopathy: A randomized controlled clinical trial

PLoS One. 2021 Mar 4;16(3): e0247663.

Contributing Authors:
E Bussin B Cairns T Gerschman M Fredericson J Bovard A Scott

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


Sixty-seven patients with Achilles tendinopathy were randomized to receive 4 weeks of daily topical diclofenac (n=32) or placebo (n=35) for the improvement of symptoms. The primary outcome of interest was physical function measured with the Victorian Institute of Sports Assessment - Achilles (VISA-A) score. Secondary outcomes of interest included pain at rest and during loading on a pain rating sc...

Ace Report Preview Image
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.